These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1846278)
21. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022 [TBL] [Abstract][Full Text] [Related]
23. A prospective study of hepatitis C viremia in renal allograft recipients. Mahmoud IM; Sobh MA; Amer GM; El-Chenawy FA; Gazareen SH; El-Sherif A; El-Sawy E; Ghoneim MA Am J Nephrol; 1999; 19(5):576-85. PubMed ID: 10575187 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H J Hepatol; 1992 May; 15(1-2):202-6. PubMed ID: 1324270 [TBL] [Abstract][Full Text] [Related]
25. [Prevalence of antibodies against hepatitis C virus (anti HCV) in different populations with chronic liver disease using the first generation test]. Findor JA; Silva M; Medina M; Bruch Igartúa E; Sordá J; Findor AJ; Schiff E Acta Gastroenterol Latinoam; 1991; 21(4):221-5. PubMed ID: 1668600 [TBL] [Abstract][Full Text] [Related]
26. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients. Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588 [TBL] [Abstract][Full Text] [Related]
27. Risk of liver disease in HCV-seropositive kidney transplant recipients. Rohr MS; Lesniewski RR; Rubin CA; Johnson RG; Heise ER; McDonald JC; Adams PL Ann Surg; 1993 May; 217(5):512-6; discussion 516-7. PubMed ID: 8387764 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Stempel CA; Lake J; Kuo G; Vincenti F Transplantation; 1993 Feb; 55(2):273-6. PubMed ID: 7679527 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients. Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953 [TBL] [Abstract][Full Text] [Related]
30. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members]. Miyasaka M Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830 [TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of liver cirrhosis in alcoholic patients: histological evidence for hepatitis C virus responsibility. Halimi C; Dény P; Gotheil C; Trinchet JC; Mal F; Scavizzi M; Beaugrand M Liver; 1991 Dec; 11(6):329-33. PubMed ID: 1664014 [TBL] [Abstract][Full Text] [Related]
32. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400 [TBL] [Abstract][Full Text] [Related]
33. Detection of antibody to hepatitis C virus in renal transplant recipients. Roth D; Fernandez JA; Burke GW; Esquenazi V; Miller J Transplantation; 1991 Feb; 51(2):396-400. PubMed ID: 1847250 [TBL] [Abstract][Full Text] [Related]
34. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Féray C; Gigou M; Samuel D; Ducot B; Maisonneuve P; Reynès M; Bismuth A; Bismuth H Ann Intern Med; 1998 May; 128(10):810-6. PubMed ID: 9599192 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Strasser SI; Myerson D; Spurgeon CL; Sullivan KM; Storer B; Schoch HG; Kim S; Flowers ME; McDonald GB Hepatology; 1999 Jun; 29(6):1893-9. PubMed ID: 10347135 [TBL] [Abstract][Full Text] [Related]
36. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Shah G; Demetris AJ; Gavaler JS; Lewis JH; Todo S; Starzl TE; Van Thiel DH Gastroenterology; 1992 Jul; 103(1):323-9. PubMed ID: 1612340 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community. Barnes RE; Meyer RA; Gordon SC Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412 [TBL] [Abstract][Full Text] [Related]
38. Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. Shah G; Demetris AJ; Irish W; Scheffel J; Mimms L; Van Thiel DH J Hepatol; 1993 Jul; 18(3):279-83. PubMed ID: 8228120 [TBL] [Abstract][Full Text] [Related]
39. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of anti-HCV among Chinese patients with acute and chronic liver disease. Lee SD; Wang YJ; Lin HC; Wu JC; Chan CY; Huang YS; Tsai YT; Lo KJ J Gastroenterol Hepatol; 1992; 7(2):113-6. PubMed ID: 1315164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]